Godavari Drugs Q2 Results

  • BSE: 530317
  • NSE: -
  • ISIN: INE362C01012
  • Sector: Biotechnology & Drugs
BSE
114.5-0.05 (-0.04%)
Volume12.92 K
Updated: Wed 27 Nov, 2024 | 15:23:33
NSE
This stock is not traded on NSE
Today: 110.00
115.80
52-Wk: 86.99
155.00

Q2 Results Highlights

  • Total Income
    ₹26.09 Cr.
    (-19.00%)
  • Operating Profit
    ₹2.32 Cr.
    (-13.41%)
  • Profit After Tax
    ₹1.09 Cr.
    (-33.25%)
  • Operating Margin
    8.90%
    (37.05%)
Note: Comparison is on YoY basis

Quarterly - Godavari Drugs Q2 Results

*All figures in crores except per share values
Fiscal PeriodSep 24Jun 23QoQ CompSep 23YoY Comp
Total Revenue 26.0935.42-%39.54-%
Selling/ General/ Admin Expenses Total 1.381.22-%1.19-%
Depreciation/ Amortization 0.580.47-%0.49-%
Other Operating Expenses Total 4.243.88-%4.53-%
Total Operating Expense 23.7733.64-%36.97-%
Operating Income 2.321.77-%2.57-%
Net Income Before Taxes 1.251.12-%1.27-%
Net Income 1.090.81-%0.86-%
Diluted Normalized EPS 1.451.08-%1.14-%

Recommended For You

    More Recommendations

    Trending Stocks

      Subscribe to Our Newsletter

      Get daily newsletters around different themes from livemint.

      Subscribe
      HomeMarketsPremiumInstant LoanMint Shorts